Merck Serono fertility pens win two Red Dot awards

FERTILITY treatment pens designed by Merck Serono, the biopharmaceutical business of Merck, won over the 38-member jury of the Red Dot Award: Product Design 2015 twice at this year’s competition. The pens are used in fertility treatment to inject hormones for follicle stimulation, helping women and couples realize their dream of having a baby.

 

Merck Serono's Family of Pens is the first pre-filled, ready-to-use set of injection devices for fertility treatment. With their clear and functional product design language, the pens ranked first from among 4,928 entries from 56 countries for this year’s Red Dot Award

 

“Winning two Red Dot Awards for our Family of Pens is a remarkable achievement for Merck Serono which acknowledges our dedication and attention to detail in designing these innovative drug delivery devices to meet the needs of patients,” said Meeta Gulyani, head of Global Strategy and Franchises at Merck Serono. 

 

“Bringing to life our motto ‘As One for Patients’, developing these products was a collaborative process involving, Merck Serono´s business as well as medical device experts and our manufacturing partner the company Haselmeier. Receiving the Red Dot Awards shows that, by working together closely, we succeeded in developing devices with a unique design and high user friendliness that inspire confidence and convey reliability,” said Ms Gulyani.

 

The Red Dot Awards, which is celebrating its 60th anniversary, will be presented at a gala event in Essen, Germany on June 29. The winning products are then presented for four weeks in the special exhibition "Design on Stage" before being included in the museum's permanent exhibition. With roughly 2,000 exhibits over 4,000 square meters, the Red Dot Design Museum presents the world's largest exhibition of contemporary design.